Pre-clinical activity of tipifarnib in CTCL
A risk-adapted treatment approach for mantle cell lymphoma
ZUMA-1: updated data and future prospects
CAR T across hematological malignancies: trials to watch
Are biomarkers the future in Non-Hodgkin Lymphoma?